Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C

2016 ◽  
Vol 47 (10) ◽  
pp. 1021-1031 ◽  
Author(s):  
Toshifumi Tada ◽  
Takashi Kumada ◽  
Hidenori Toyoda ◽  
Seiki Kiriyama ◽  
Makoto Tanikawa ◽  
...  
Oncology ◽  
2016 ◽  
Vol 90 (3) ◽  
pp. 167-175 ◽  
Author(s):  
Hideo Kunimoto ◽  
Kenji Ikeda ◽  
Yushi Sorin ◽  
Shunichiro Fujiyama ◽  
Yusuke Kawamura ◽  
...  

2017 ◽  
Vol 66 (3) ◽  
pp. 504-513 ◽  
Author(s):  
Naveed Z. Janjua ◽  
Mei Chong ◽  
Margot Kuo ◽  
Ryan Woods ◽  
Jason Wong ◽  
...  

2015 ◽  
Vol 57 (6) ◽  
pp. 519-522 ◽  
Author(s):  
Angelo Alves de MATTOS ◽  
Patrícia dos Santos MARCON ◽  
Fernanda Schild Branco de ARAÚJO ◽  
Gabriela Perdomo CORAL ◽  
Cristiane Valle TOVO

Chronic infection by hepatitis C virus (HCV) is one of the main risk factors for the development of liver cirrhosis and hepatocellular carcinoma. However, the emergence of hepatocellular carcinoma (HCC) in non-cirrhotic HCV patients, especially after sustained virological response (SVR) is an unusual event. Recently, it has been suggested that HCV genotype 3 may have a particular oncogenic mechanism, but the factors involved in these cases as well as the profile of these patients are still not fully understood. Thus, we present the case of a non-cirrhotic fifty-year-old male with HCV infection, genotype 3a, who developed HCC two years after treatment with pegylated-interferon and ribavirin, with SVR, in Brazil.


2019 ◽  
Vol 70 (1) ◽  
pp. e116-e117
Author(s):  
Jason Lau ◽  
Lisette Krassenburg ◽  
Wayel R. Zanjir ◽  
Firas Georgie ◽  
Orlando Cerocchi ◽  
...  

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0185609 ◽  
Author(s):  
Swee Lin G. Chen Yi Mei ◽  
Alexander J. Thompson ◽  
Britt Christensen ◽  
Georgina Cunningham ◽  
Lucy McDonald ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document